Photo by from
Some critically ill COVID-19 patients in the Seattle area will soon receive a promising, experimental treatment derived from the blood of those who have recovered from the disease.
Doctors at Swedish Health Services hospitals hope to infuse their first patient with convalescent plasma this week.
“We’re trying to help those who need it the most first,” said Dr. Livia Hegerova, a hematologist at Swedish. Those patients who are being kept alive by ventilators and others in dire condition will receive the treatment first. Its use could later be expanded to patients who are not as desperately sick.